Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity

Marta Vaz Batista; José Perez-Garcia; Inês Eiriz; Maria Gion; Antonio Llombart; Sofia Braga; Javier Cortés

doi:10.21037/atm-23-1603

Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity

Ann Transl Med. 2023 Oct 25;11(11):398. doi: 10.21037/atm-23-1603. Epub 2023 Oct 17.

Authors

Marta Vaz Batista^{1

2

3}, José Perez-Garcia^{2

4}, Inês Eiriz¹, Maria Gion⁵, Antonio Llombart^{2

6

7}, Sofia Braga^{1

3}, Javier Cortés^{2

4

8}

Affiliations

¹ Oncology Department, Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal.
² Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, Ridgewood, NJ, USA.
³ Haematology and Oncology Department, CUF Oncology, Sintra, Portugal.
⁴ International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.
⁵ Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain.
⁶ Hospital Arnau de Vilanova, FISABIO, Valencia, Spain.
⁷ Universidad Católica de Valencia, Valencia, Spain.
⁸ Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.

No abstract available

Keywords: Brain metastases (BMs); breast cancer (BC); trastuzumab-deruxtecan (T-Dxd).

Publication types

Editorial
Comment